, a bio/informatics shared resource is still "open for business" - Visit the CDS website


Marta Crispens
Faculty Member
Last active: 3/10/2014

  1. Dioxin may promote inflammation-related development of endometriosis. Bruner-Tran KL, Yeaman GR, Crispens MA, Igarashi TM, Osteen KG (2008) Fertil Steril 89(5 Suppl): 1287-98
    › Primary publication · 18394613 (PubMed) · PMC2430157 (PubMed Central)
  2. Contrast-enhanced transvaginal sonography of benign versus malignant ovarian masses: preliminary findings. Fleischer AC, Lyshchik A, Jones HW, Crispens M, Loveless M, Andreotti RF, Williams PK, Fishman DA (2008) J Ultrasound Med 27(7): 1011-8; quiz 1019-21
    › Primary publication · 18577664 (PubMed)
  3. Intraperitoneal chemotherapy for ovarian cancer: overview and perspective. Rao G, Crispens M, Rothenberg ML (2007) J Clin Oncol 25(20): 2867-72
    › Primary publication · 17617517 (PubMed)
  4. Comparison of the clinical behavior of newly diagnosed stages II-IV low-grade serous carcinoma of the ovary with that of serous ovarian tumors of low malignant potential that recur as low-grade serous carcinoma. Shvartsman HS, Sun CC, Bodurka DC, Mahajan V, Crispens M, Lu KH, Deavers MT, Malpica A, Silva EG, Gershenson DM (2007) Gynecol Oncol 105(3): 625-9
    › Primary publication · 17320156 (PubMed)
  5. Sonographic depiction of intratumoral vascularity with 2- and 3-dimensional color Doppler techniques. Fleischer AC, Milam MR, Crispens MA, Shappell HW (2005) J Ultrasound Med 24(4): 533-7
    › Primary publication · 15784771 (PubMed)
  6. Squamous cell carcinoma of the cervix presenting as lymphangitic carcinomatosis: a case report and review of the literature. Storck K, Crispens M, Brader K (2004) Gynecol Oncol 94(3): 825-8
    › Primary publication · 15350381 (PubMed)
  7. Retroperitoneal fibrosis secondary to actinomycosis with no intrauterine device. Milam MR, Schultenover SJ, Crispens M, Parker L (2004) Obstet Gynecol 104(5 Pt 2): 1134-6
    › Primary publication · 15516426 (PubMed)
  8. Borderline ovarian tumours: a review of the recent literature. Crispens MA (2003) Curr Opin Obstet Gynecol 15(1): 39-43
    › Primary publication · 12544500 (PubMed)
  9. Response and survival in patients with progressive or recurrent serous ovarian tumors of low malignant potential. Crispens MA, Bodurka D, Deavers M, Lu K, Silva EG, Gershenson DM (2002) Obstet Gynecol 99(1): 3-10
    › Primary publication · 11777502 (PubMed)
  10. Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice. Yoneda J, Kuniyasu H, Crispens MA, Price JE, Bucana CD, Fidler IJ (1998) J Natl Cancer Inst 90(6): 447-54
    › Primary publication · 9521169 (PubMed)